|Articles|January 15, 2002
CDC focuses on medical response to bioterrorism threat
Baltimore-The Centers for Disease Control and Prevention (CDC) has been at the forefront of the medical response to the bioterrorism threat in recent months since the first case of inhalation anthrax was identified.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Neurotrophic keratitis outcomes improve with early, stage-based care
2
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
3
FDA feedback supports Azura’s Ophthalmic's planned NDA for AZR-MD-001 in MGD
4
Alcon raises offer in amended deal to acquire STAAR Surgical
5








































.png)


